药物分析学报（英文）2023，Vol.13Issue(12)：1375-1387,13.DOI:10.1016/j.jpha.2023.08.013
Ginsenoside Rc:A potential intervention agent for metabolic syndrome
Ginsenoside Rc:A potential intervention agent for metabolic syndrome
Zhengjie Lu 1Tongyun Mao 2Kaiqi Chen 2Longxin Chai 3Yongguo Dai 2Kexin Liu4
作者信息
- 1. Department of Pharmacy,Zhongnan Hospital of Wuhan University,Wuhan,430072,China||Department of Orthopedic Surgery,Zhongnan Hospital of Wuhan University,Wuhan,430072,China||Department of Pharmacology,Wuhan University School of Basic Medical Sciences,Wuhan,430071,China
- 2. Department of Pharmacology,Wuhan University School of Basic Medical Sciences,Wuhan,430071,China
- 3. School of Life Sciences,Hubei University,Wuhan,430062,China
- 4. Department of Pharmacy,Zhongnan Hospital of Wuhan University,Wuhan,430072,China||Department of Pharmacology,Wuhan University School of Basic Medical Sciences,Wuhan,430071,China
- 折叠
摘要
关键词
Ginsenoside Rc/Metabolic syndrome/Obesity/Diabetes/AtherosclerosisKey words
Ginsenoside Rc/Metabolic syndrome/Obesity/Diabetes/Atherosclerosis引用本文复制引用
Zhengjie Lu,Tongyun Mao,Kaiqi Chen,Longxin Chai,Yongguo Dai,Kexin Liu..Ginsenoside Rc:A potential intervention agent for metabolic syndrome[J].药物分析学报（英文）,2023,13(12):1375-1387,13.
